Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | +5.81% | +10.75% | +17.67% |
09/05 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.67% | 32Cr | |
+9.42% | 11TCr | |
+11.84% | 10TCr | |
-14.15% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.16% | 1.79TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.25TCr |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- JPMorgan Downgrades Mersana Therapeutics to Underweight From Neutral